Literature DB >> 22093604

Medulloblastoma presenting as dialysis disequilibrium syndrome.

Robertino Dilena1, Fabio Paglialonga, Sergio Barbieri, Alberto Edefonti.   

Abstract

Dialysis disequilibrium syndrome (DDS) is a central nervous system disorder that occurs during or after hemodialysis. This is caused by brain edema that manifests as neurological symptoms that include headache, emesis, nausea, blurring of vision, disturbed consciousness, tremors and seizures, and in severe cases, death. The incidence of DDS is very high among patients with preexisting neurological diseases. There has been much debate about the origin of DDS. We report a case of DDS, as presenting syndrome of a medulloblastoma in a child aged 5 years, and discuss the pathogenesis and the possible role of DDS for an earlier detection of occult brain lesions in dialyzed patients. 2011 The Authors; Hemodialysis International. 2011 International Society for Hemodialysis.

Entities:  

Mesh:

Year:  2011        PMID: 22093604     DOI: 10.1111/j.1542-4758.2011.00604.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  4 in total

1.  Headache during haemodialysis in a patient with shunt: a cause for concern?

Authors:  Padraig O'Sullivan; Jahangir Sajjad; Sahibzada Abrar; Charles Marks
Journal:  BMJ Case Rep       Date:  2015-03-27

2.  Medulloblastoma treatment in a child on dialysis.

Authors:  Nadia Puma; Veronica Biassoni; Lorenza Gandola; Emilia Pecori; Gianluigi Ardissino; Fabio Paglialonga; Alice Indini; Manila Antonelli; Maura Massimino
Journal:  CNS Oncol       Date:  2014-01

3.  Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis.

Authors:  Yohei Tsuchida; Takuma Takata; Toshihiko Ikarashi; Noriaki Iino; Junichiro J Kazama; Ichiei Narita
Journal:  BMC Nephrol       Date:  2013-11-18       Impact factor: 2.388

4.  The CSF Diversion via Lumbar Drainage to Treat Dialysis Disequilibrium Syndrome in the Critically Ill Neurological Patient.

Authors:  Christopher S Hong; Kevin Wang; Guido J Falcone
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.